BiotechTube
Home/Neurophth Therapeutics/Wei Yan
WY

Wei Yan

Vice President of Finance

Neurophth Therapeutics

Therapeutic Areas

OphthalmologyRare Diseases

Neurophth Therapeutics Pipeline

DrugIndicationPhase
NFS-01 (NR082/rAAV2-ND4)Leber's Hereditary Optic Neuropathy (LHON) due to ND4 mutationPhase 3
NFS-02 (rAAV2-ND1)Leber's Hereditary Optic Neuropathy (LHON) due to ND1 mutationPhase 1/2
Pipeline CandidatesDominant Optic Atrophy, Optic Nerve Injury, Vascular RetinopathiesPreclinical

Leadership Team at Neurophth Therapeutics

BL
Bin Li
Founder, Chairman, Chief Scientific Officer
SX
Su Xiao
Co-Founder
DC
Dabo Cai
Co-Founder, Head of Sales & Operations
ZL
Zhengbin Li
Chief Executive Officer
JY
Jie Yang
Executive Director of Human Resources
View full Neurophth Therapeutics profile